386 PCA3 and T2-ERG add further predictive and clinical benefit to the detection of prostate cancer in men of various ages in the early detection research network (EDRN)
O'Malley, P., Golombos, D., Lewicki, P., Al Hussein Al Awamlh, B., Christos, P., Sanda, M., Thompson, IM, Wei, J., Rubin, M., Barbieri, C., Scherr, D.Volume:
15
Language:
english
Journal:
European Urology Supplements
DOI:
10.1016/s1569-9056(16)60388-3
Date:
March, 2016
File:
PDF, 109 KB
english, 2016
File converter
More search results
More benefits 
